These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21888783)

  • 1. Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States.
    Atkins CY; Patel A; Taylor TH; Biggerstaff M; Merlin TL; Dulin SM; Erickson BA; Borse RH; Hunkler R; Meltzer MI
    Emerg Infect Dis; 2011 Sep; 17(9):1591-8. PubMed ID: 21888783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.
    Borders-Hemphill V; Mosholder A
    Influenza Other Respir Viruses; 2012 Nov; 6(6):e129-33. PubMed ID: 22681766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community.
    Xiao Y; Patel Z; Fiddler A; Yuan L; Delvin ME; Fisman DN
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1409-15. PubMed ID: 23879801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015.
    Appiah GD; Chaves SS; Kirley PD; Miller L; Meek J; Anderson E; Oni O; Ryan P; Eckel S; Lynfield R; Bargsten M; Zansky SM; Bennett N; Lung K; McDonald-Hamm C; Thomas A; Brady D; Lindegren ML; Schaffner W; Hill M; Garg S; Fry AM; Campbell AP
    Clin Infect Dis; 2017 Feb; 64(3):364-367. PubMed ID: 28013261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11.
    Lackenby A; Moran Gilad J; Pebody R; Miah S; Calatayud L; Bolotin S; Vipond I; Muir P; Guiver M; McMenamin J; Reynolds A; Moore C; Gunson R; Thompson C; Galiano M; Bermingham A; Ellis J; Zambon M
    Euro Surveill; 2011 Feb; 16(5):. PubMed ID: 21315056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.
    Storms AD; Gubareva LV; Su S; Wheeling JT; Okomo-Adhiambo M; Pan CY; Reisdorf E; St George K; Myers R; Wotton JT; Robinson S; Leader B; Thompson M; Shannon M; Klimov A; Fry AM;
    Emerg Infect Dis; 2012 Feb; 18(2):308-11. PubMed ID: 22305467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.
    Poeppl W; Hell M; Herkner H; Stoiser B; Fritsche G; Schurz-Bamieh N; Poeppl G; Gattringer R; Jones N; Maass M; Egle A; Burgmann H
    Infection; 2011 Aug; 39(4):341-52. PubMed ID: 21544585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.
    Seale AC; Toussaint FS; Finn A; Fraser JI
    Arch Dis Child; 2011 Sep; 96(9):902-3. PubMed ID: 20702390
    [No Abstract]   [Full Text] [Related]  

  • 9. Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
    Franklin JM; Choudhry NK; Uscher-Pines L; Brill G; Matlin OS; Fischer MA; Schneeweiss S; Avorn J; Brennan TA; Shrank WH
    Am J Public Health; 2014 Jun; 104(6):1052-8. PubMed ID: 24825206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
    Ujike M; Ejima M; Anraku A; Shimabukuro K; Obuchi M; Kishida N; Hong X; Takashita E; Fujisaki S; Yamashita K; Horikawa H; Kato Y; Oguchi A; Fujita N; Tashiro M; Odagiri T;
    Emerg Infect Dis; 2011 Mar; 17(3):470-9. PubMed ID: 21392439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.
    Chowell G; Viboud C; Simonsen L; Miller MA; Echevarría-Zuno S; González-León M; Aburto VH
    BMC Infect Dis; 2012 Apr; 12():97. PubMed ID: 22520743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment.
    Hernandez JE; Grainger J; Simonsen L; Collis P; Edelman L; Sheridan WP
    Influenza Other Respir Viruses; 2012 Sep; 6(5):305-8. PubMed ID: 22085222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).
    Shrestha SS; Swerdlow DL; Borse RH; Prabhu VS; Finelli L; Atkins CY; Owusu-Edusei K; Bell B; Mead PS; Biggerstaff M; Brammer L; Davidson H; Jernigan D; Jhung MA; Kamimoto LA; Merlin TL; Nowell M; Redd SC; Reed C; Schuchat A; Meltzer MI
    Clin Infect Dis; 2011 Jan; 52 Suppl 1():S75-82. PubMed ID: 21342903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
    Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
    PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 58(51):1436-40. PubMed ID: 20057350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.
    Greene SK; Shay DK; Yin R; McCarthy NL; Baxter R; Jackson ML; Jacobsen SJ; Nordin JD; Irving SA; Naleway AL; Glanz JM; Lieu TA
    Influenza Other Respir Viruses; 2012 Nov; 6(6):e143-51. PubMed ID: 22687171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.
    Yi H; Lee JY; Hong EH; Kim MS; Kwon D; Choi JH; Choi WY; Kim KS; Lee JK; Oh HB; Kang C
    Emerg Infect Dis; 2010 Dec; 16(12):1938-42. PubMed ID: 21122225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.